LCM
USNA icon

Laurion Capital Management’s Usana Health Sciences USNA Stock Holding History

Laurion Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,229
Closed -$690K – 1197
2019
Q1 		$690K Buy
+8,229
New +$859K 0.01% 577
2015
Q4 		– Sell
-4,400
Closed -$295K – 1061
2015
Q3 		$295K Buy
+4,400
New +$311K ﹤0.01% 576

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Laurion Capital Management's USNA Position: Q2 2019 in Review

Laurion Capital Management sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 8,229 shares — an estimated $690K sold.

Laurion Capital Management first reported a position in USNA in Q3 2015 and held it in 2 quarters. The position peaked at $690K in Q1 2019. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Laurion Capital Management reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Laurion Capital Management sold 8,229 Usana Health Sciences shares in Q2 2019, an estimated $690K.
  • Laurion Capital Management first reported a position in Usana Health Sciences in Q3 2015 and held it in 2 quarters.
  • Laurion Capital Management's Usana Health Sciences position peaked at $690K in Q1 2019.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Laurion Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.